Wolverine Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-192,103
| Closed | -$584K | – | 1497 |
|
|
2024
Q4 | $584K | Sell |
192,103
-39,297
| -17% | -$119K | 0.01% | 530 |
|
|
2024
Q3 | $1.2M | Buy |
231,400
+228,896
| +9,141% | +$1.19M | 0.01% | 371 |
|
|
2024
Q2 | $6.44K | Sell |
2,504
-3,000
| -55% | -$7.71K | ﹤0.01% | 961 |
|
|
2024
Q1 | $27.1K | Hold |
5,504
| – | – | ﹤0.01% | 806 |
|
|
2023
Q4 | $48.4K | Buy |
+5,504
| New | +$48.4K | ﹤0.01% | 815 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1687 |
|
|
2021
Q2 | – | Sell |
-1,710
| Closed | -$47K | – | 2253 |
|
|
2021
Q1 | $47K | Buy |
+1,710
| New | +$47K | ﹤0.01% | 1399 |
|